EUVIMEDEUVIMED entdecken
Crossref

A TNBC-targeting nano-radiosensitizer reverses radioresistance by synergizing GSH scavenging with dual inhibition of Trop2 and lncRNA MNX1-AS1

Zhiwei Yang, Bianfei Shao, Danni Wang, Hongwei Chen, Xiaohui Zhao, Minghui Zeng, Yimin Liu, Qingjian Li, Zhuofei Bi

Biomaterials · 2026

DOI: 10.1016/j.biomaterials.2025.123787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials, 2026. Verfasst von Zhiwei Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Mal…. Hauptthemen laut MEDLINE: Glutathione, Triple Negative Breast Neoplasms, RNA, Long Noncoding, Antigens, Neoplasm. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Sun Yat-sen University, Traditional Chinese Medicine Bureau of Guangdong Province, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radioresistance in triple-negative breast cancer (TNBC) frequently results in local recurrence and distant metastasis, seriously affecting the prognosis of patients. The increased generation of cellular glutathione (GSH) and the upregulation of pro-malignant molecules are two major causes of radioresistance in TNBC, which need to be comprehensively considered in treatment. Herein, a TNBC-targeted reduction-responsive RNA interference (RNAi) nano-radiosensitizer (TREARA) was developed to reverse radioresistance by synergizing GSH depletion with combined inhibition of two promising pro-malignant molecules, Trophoblast cell surface antigen 2 (Trop2) and lncRNA Motor neuron and pancreas homeobox 1-antisense RNA1 (lncMNX1-AS1). Once arriving at the tumor sites with the prolonged circulation maintained by PEGylation, TREARA was rapidly internalized by tumor cells and blocked the Trop2-dominant pro-metastatic signaling through the anti-Trop2 antibody (αTrop2) modified on its surface. Subsequently, in response to the highly concentrated GSH in the cytoplasm, the shell of TREARA containing poly (disulfide amide) polymer (PDSA) was broken, releasing the loaded lncMNX1-AS1 siRNA (siMNX1-AS1), which would suppress tumor progression by inactivating JAK3/STAT3 signaling. Benefiting from the integration of GSH-scavenging and dual-targeted inhibition of Trop2 and lncMNX1-AS1, TREARA significantly reversed radioresistance and restrained metastasis in murine models. Taken together, TREARA provides a promising comprehensive perspective for refractory radioresistant TNBC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlutathioneTriple Negative Breast NeoplasmsRNA, Long NoncodingAntigens, NeoplasmRadiation-Sensitizing AgentsCell Adhesion MoleculesRadiation ToleranceNanoparticlesHumansAnimalsCell Line, TumorFemaleMice, NudeMice, Inbred BALB CMice

Stichwörter der Autor:innen

Nano-radiosensitizerRadioresistanceReduction-responsive RNA interference (RNAi) nanoplatformTriple-negative breast cancer (TNBC)Trop2lncMNX1-AS1

Substanzen

GlutathioneRNA, Long NoncodingAntigens, NeoplasmRadiation-Sensitizing AgentsCell Adhesion MoleculesTACSTD2 protein, human

Autor:innen und Institutionen

  • Department of Radiation Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hos…
  • Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China.
  • Department of Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun…

Förderung

  • Sun Yat-sen University
  • Traditional Chinese Medicine Bureau of Guangdong Province
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation
  • Chongqing University
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Natural Science Foundation of China
  • Guangzhou Municipal Science and Technology Program key projects

Zitieren

APA

Yang, Z., Shao, B., Wang, D., Chen, H., Zhao, X., Zeng, M., Liu, Y., Li, Q., & Bi, Z. (2026). A TNBC-targeting nano-radiosensitizer reverses radioresistance by synergizing GSH scavenging with dual inhibition of Trop2 and lncRNA MNX1-AS1. Biomaterials. https://doi.org/10.1016/j.biomaterials.2025.123787

Vancouver

Yang Z, Shao B, Wang D, Chen H, Zhao X, Zeng M, et al. A TNBC-targeting nano-radiosensitizer reverses radioresistance by synergizing GSH scavenging with dual inhibition of Trop2 and lncRNA MNX1-AS1. Biomaterials. 2026. doi:10.1016/j.biomaterials.2025.123787

BibTeX
@article{Yang2026,
  author = {Yang, Zhiwei and Shao, Bianfei and Wang, Danni and Chen, Hongwei and Zhao, Xiaohui and Zeng, Minghui and Liu, Yimin and Li, Qingjian and Bi, Zhuofei},
  title = {A TNBC-targeting nano-radiosensitizer reverses radioresistance by synergizing GSH scavenging with dual inhibition of Trop2 and lncRNA MNX1-AS1},
  journal = {Biomaterials},
  year = {2026},
  doi = {10.1016/j.biomaterials.2025.123787}
}
Kostenlos starten →